Security Snapshot

Jaguar Health, Inc. - Common stock, par value $0.0001 per share (JAGX) Institutional Ownership

CUSIP: 47010C805

13F Institutional Holders and Ownership History from Q1 2022 to Q1 2025

Latest Period

n/a

Institutions Reporting

Shares (Excl. Options)

Price

$0.25

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Type / Class
Equity / Common stock, par value $0.0001 per share
Symbol
JAGX on Nasdaq
Shares outstanding
3,171,247
Price per share
$0.25
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Quick Takeaways

  • JAGX - Jaguar Health, Inc. - Common stock, par value $0.0001 per share is tracked under CUSIP 47010C805.
  • Latest finished 13F holder period is not available.
  • 1 significant owner is listed from Schedule 13D/13G reporting.

What Changed

  • Holder count moved from 12 to 0 between Q4 2024 and Q1 2025.
  • Reported value moved from $283,443 to $0.

Why This Matters

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Source Evidence

Source: SEC Schedule 13D/G

Ownership context comes from Schedule 13D/G and available holder history for this CUSIP.

Open SEC Evidence

Investment Quick Answers

What is CUSIP 47010C805?
CUSIP 47010C805 identifies JAGX - Jaguar Health, Inc. - Common stock, par value $0.0001 per share in SEC 13F datasets.

Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.

Significant Owners of Jaguar Health, Inc. - Common stock, par value $0.0001 per share (JAGX) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Uptown Capital, LLC 9.9% $322,500 1,290,000 John Fife and Fredrick Waid 29 Jan 2025

Institutional Holders of Jaguar Health, Inc. - Common stock, par value $0.0001 per share (JAGX) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q1 0 $0 -$283,443 $0.25 0
2024 Q4 280,637 $283,443 -$29,972 $1.01 12
2024 Q3 286,131 $387,089 +$142,262 $1.35 13
2024 Q2 102,458 $366,975 +$366,975 $3.58 12
2023 Q2 0 $0 -$2 $0.25 0
2023 Q1 3 $2 -$165 $0.67 1
2022 Q4 250 $22 $0.09 1
2022 Q3 250 $39 $0.16 1
2022 Q2 250 $74 $0.30 1
2022 Q1 250 $177 $0.71 1
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .